NCT00631982UnknownNot Applicable
In Vitro Maturation of Oocytes for Patients With Polycystic Ovaries
Assaf-Harofeh Medical Center2 sites in 1 country30 target enrollmentStarted: April 2008Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Assaf-Harofeh Medical Center
- Enrollment
- 30
- Locations
- 2
- Primary Endpoint
- maturation rate,
Study Overview
Brief Summary
In vitro maturation of oocytes after minimal gonadotropin stimulation in patients with polycystic ovaries, to prevent cases of ovarian hyperstimulation.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 39 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Polycystic ovaries
- •Needing IVF for fertility treatment
Exclusion Criteria
- •Age above 39
Outcomes
Primary Outcomes
maturation rate,
Time Frame: 18 months
Secondary Outcomes
- Fertilization rate, pregnancy rate(18 months)
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
In-Vitro Maturation of Oocytes From Polycystic Ovarian Patients Undergoing IVFPolycystic Ovarian SyndromeNCT00561808Hillel Yaffe Medical Center30
Completed
Not Applicable
In Vitro Maturation (IVM) for Polycystic Ovary Syndrome (PCOS)Polycystic Ovarian SyndromeNCT01237106University Reproductive Associates10
Withdrawn
Not Applicable
In Vitro Maturation (IVM) of Human OocytesPolycystic Ovarian Syndrome (PCOS)Patients Sensitive to Exogenous GonadotropinsOvarian Hyper Stimulation Syndrome (OHSS)NCT01843569Northwell Health
Recruiting
Not Applicable
In vitro maturation of immature human oocytesInfertilityJPRN-UMIN000032035Hyogo College of Medicine, Department of Obstetrics and Gynecology200
Completed
Not Applicable
In Vitro Maturation of Immature OocytesPolycystic Ovary SyndromeOvarian Hyperstimulation SyndromeNCT00480337Sheba Medical Center